Effects of Fullerenol C₆₀(OH)₂₄ Nanoparticles on a Single-dose Doxorubicin-induced Cardiotoxicity in Pigs: An Ultrastructural Study

References

• Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125: 47–58
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Boskovic M, et al. Cardioprotective effects of fullerenol C60(OH)24 on a single-dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm. Technol Cancer Res Treat 2008;7: 15–26
   PubMedGoogle Scholar
• Injac R, Strukelj B. Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat 2008;7: 497–516
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Rajesh M, Bátkai S, et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009;296: H1466–83
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Fabbi P, Manca V, et al. Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis. Biochem Biophys Res Commun 2005;335: 188–96
   PubMedGoogle Scholar
• Schoen FJ. The heart: other specific causes of myocardial disease – adriamycin and other drugs. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and cotran pathologic basis of disease, 7th ed. Philadelphia: Elsevier Saunders, 2005:609
   Google Scholar
• Injac R, Perse M, Obermajer N, et al. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 2008;29: 3451–60
   PubMed Web of Science ®Google Scholar
• Injac R, Boskovic M, Perse M, et al. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm is successfully treated with fullerenol C60(OH)24 through suppression of oxidative stress. Pharmacol Rep 2008;60: 742–9
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Cerne M, et al. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 2009;30: 1184–96
   PubMed Web of Science ®Google Scholar
• Injac R, Radic N, Govedarica B, et al. Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through inhibition of oxidative stress. Pharmacol Rep 2009;61: 335–42
   PubMed Web of Science ®Google Scholar
• Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28: 295–302
   PubMed Web of Science ®Google Scholar
• MrĐanović JŽ, Šolajić SV, Bogdanović VV, et al. Effects of fullerenol nano particles C60(OH)24 on micronuclei and chromosomal aberrations' frequency in peripheral blood lymphocytes. Digest J Nanomater Biostruct 2012;7: 673–86
   Google Scholar
• Aupperle H, Garbade J, Ullman CH, et al. Comparing the ultrastructural effects of two different cardiac preparation and perfusion techniques in a porcine model of extracorporeal long-term preservation. Eur J Cardio-Thorac Surg 2007;31: 214–21
   PubMedGoogle Scholar
• Kumar V, Abbas AK, Fausto N. Cellular adaptation, cell injury and cell death. In: Kumar V, Abbas AK, Fausto N, eds. Robbins and cotran pathologic basis of disease, 7th ed. Philadelphia: Elsevier Saunders, 2005:3–47
   Google Scholar
• Alto LE, Singal PK, Dhalla NS. Calcium paradox: dependence of reperfusion-induced changes on the extracellular calcium concentration. Adv Myocardiol 1980;2: 177–85
   PubMedGoogle Scholar
• Stoica SC, Satchithananda DK, Dunning J, Large SR. Two-decade analysis of cardiac storage for transplantation. Eur J Cardio Thoracic Surg 2001;20: 792–8
   PubMedGoogle Scholar
• Arbustini E, Brega A, Narula J. Ultrastructural definition of apoptosis in heart failure. Heart Fail Rev 2008;13: 121–35
   PubMedGoogle Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87: 315–424
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Garibaldi S, Altieri P, et al. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 2004;37: 837–46
   PubMed Web of Science ®Google Scholar
• Ohno M, Takemura G, Ohno A, et al. “Apoptotic” myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electron microscopy combined with in situ nick end-labelling. Circulation 1998;98: 1422–30
   PubMed Web of Science ®Google Scholar
• Bogdanovic G, Kojic V, Djordjevic A, et al. Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity. Toxicol In Vitro 2004;18: 629–37
   PubMed Web of Science ®Google Scholar
• Mirkov S, Djordjevic A, Andric N, et al. Nitric oxide-scavenging activity of polyhydroxylated fullerenol. Nitric Oxide: Biol Chem 2004;11: 201–7
   PubMed Web of Science ®Google Scholar
• Djordjevic A, Canadanovic-Brunet J, Vojinovic-Miloradov M, Bogdanovic G. Antioxidant properties and hypothetical radical mechanism of fullerol C60(OH)24. Oxidation Commun 2005;27: 806–12
   Google Scholar
• Trajković S, Dobrić S, Jaćević V, et al. Tissue-protective effects of fullerenol C60(OH)24 andamifostine in irradiated rats. Colloids Surf B 2007;58: 39–43
   PubMed Web of Science ®Google Scholar
• Djordjevic A, Bogdanovic G, Dobric S. Fullerens in biomedicine. J BUON 2006;11: 391–404
   PubMedGoogle Scholar
• Milic Torres V, Srdjenovic B, Jacevic V, et al. Fullerenol C60(OH)24 prevents doxorubicin-induced acute cardiotoxicity in rats. Pharmacol Rep 2010;62: 707–18
   PubMedGoogle Scholar
• Injac R, Radic N, Govedarica B, et al. Bioapplication and activity of fullerenol C60(OH)24. Afr J Biotechnol 2008;7: 4940–50
   Google Scholar
• Perše M, Injac R, Djordjevic A, et al. Protective effect of fullerenol nano particles on colon cancer development in dimethylhydrazine rat model. Digest J Nanomater Biostruct 2011;6: 1543–51
   Google Scholar
• Pinteala M, Dascalu A, Ungurenasu C. Binding fullerenol C60(OH)24 to dsDNA. Int J Nanomed 2009;4: 193–9
   PubMed Web of Science ®Google Scholar
• Isakovic A, Markovic Z, Todorovic-Markovic B, et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 2006;91: 173–83
   PubMed Web of Science ®Google Scholar
• Olivetti G, Cigola E, Maestri R, et al. Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 1996;28: 1463–77
   PubMed Web of Science ®Google Scholar
• Engel FB. Cardiomyocyte proliferation: a platform for mammalian cardiac repair. Cell Cycle 2005;4: 1360–3
   PubMed Web of Science ®Google Scholar
• Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977;51: 186–273
   PubMedGoogle Scholar
• Buja M, Vela D. Cardiomyocyte and renewal in the normal and diseased heart. Cardiovasc Pathol 2008;17: 349–74
   PubMed Web of Science ®Google Scholar
• Katz EB, Steinhelper ME, Delcarpio JB, et al. Cardiomyocyte proliferation in mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen transgenes. Am J Physiol Heart Circ Physiol 1992;262: H1867–76
   PubMedGoogle Scholar
• Liu Y, Kitsis RN. Induction of DNA synthesis and apoptosis in cardiac myocytes by E1A oncoprotein. J Cell Biol 1996;133: 325–34
   PubMedGoogle Scholar
• Engel FB, Schebesta M, Duong MT, et al. P38 MAP kinase inhibition enables proliferation of adult mammalian cariomyocytes. Genes Dev 2005;19: 1175–87
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Altieri P, Garibaldi S, et al. Matrix metalloproteinase-2 and-9 induced differently by doxorubicin in H9c2 cells: the role of MAP kinases and NAD(P)H oxidase. Cardiovasc Res 2006;69: 736–45
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Altieri P, Aloi C, et al. Doxorubicin induces senescence or apoptosis in rat neonatal cariomyocytes by regulating the expression levels of the telomere binding factors 1 and 2. Am J Physiol Heart Circ Physiol 2009;297: H2169–81
   PubMed Web of Science ®Google Scholar
• Castedo M, Perfettini JL, Roumier T, et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23: 2825–37
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324: 98–102
   PubMed Web of Science ®Google Scholar